Maartje A C E van Kats

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry

M. Pepels, V. Tjan-Heijnen, F. Erdkamp, 2023, The Lancet regional health. Europe.

Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis

L. Kooreman, S. Siesling, T. V. van Nijnatten, 2022, Breast Cancer Research and Treatment.